In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

BioPharmX Corp.. Trade Record

AMEX:BPMX BioPharmX Corp. stock gains 7.04% Exit Jan 12, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart BPMX Jan 11, 2017, priceSeries
About BioPharmX Corp.

BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women's health and dermatology markets. The company offers prescription and over-the-counter (OTC) products in oral, topical, and injectable forms. It provides VI2OLET iodine, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort and for the alleviation of symptoms of fibrocystic breast condition (FBC). The company's clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician's practices, including obstetricians and gynecologists, dermatologists, and general practitioners; and retail customers through retail sales channels and/or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.

Trade Information
Trade Type
Entry Date
Jan 11, 2017
Entry Price
Sell Date
Jan 12, 2017
Sell Price
Net Gain
Hold Time
1 Trading Days